These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3918963)

  • 1. The Piotron: II. Methods and initial results of dynamic pion therapy in phase II studies.
    von Essen CF; Blattmann H; Bodendoerfer G; Mizoe J; Pedroni E; Walder E; Zimmermann A
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):217-26. PubMed ID: 3918963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the SIN and Los Alamos Pion Trials.
    Schmitt G; von Essen CF; Greiner R; Blattmann H
    Radiat Res Suppl; 1985; 8():S272-8. PubMed ID: 3937174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of a Phase I/II study with pi-meson (pion) treatment for bladder cancer.
    Studer UE; Von Essen CF; Enderli JB; Bodendörfer G; Zingg EJ
    Cancer; 1985 Oct; 56(8):1943-52. PubMed ID: 3928134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late results in patients treated with pi-mesons for bladder cancer.
    Studer UE; Gerber E; Zimmermann A; Kraft R; von Essen CF
    Cancer; 1993 Jan; 71(2):439-47. PubMed ID: 8422636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of pion therapy at Los Alamos.
    von Essen CF; Bagshaw MA; Bush SE; Smith AR; Kligerman MM
    Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1389-98. PubMed ID: 3114189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pion therapy at SIN--7 years' experience].
    Karasawa K
    Gan No Rinsho; 1988 Oct; 34(13):1845-51. PubMed ID: 3199517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PIOTRON: initial performance, preparation and experience with pion therapy.
    von Essen CF; Blattmann H; Crawford JF; Fessenden P; Pedroni E; Perret C; Salzmann M; Shortt K; Walder E
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1499-509. PubMed ID: 6815138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportional counter dosimetry and microdosimetry for radiotherapy with multiple pion beams.
    Schuhmacher H; Menzel HG; Blattmann H; Muth H
    Radiat Res; 1985 Jan; 101(1):177-96. PubMed ID: 3918330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pions--the potential for therapeutic gain in locally advanced prostate cancer: dose escalation and toxicity studies.
    Pickles T; Bowen J; Dixon P; Gaffney C; Pomeroy M; Rheaume D; Vernimmen F; Goodman GB
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1005-11. PubMed ID: 1917595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pion radiotherapy at LAMPF.
    Bush SE; Smith AR; Zink S
    Int J Radiat Oncol Biol Phys; 1982 Dec; 8(12):2181-6. PubMed ID: 6298158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of curative pion therapy at SIN.
    Greiner R; von Essen CF; Blattmann H; Studer U; Zimmermann A; Bodendoerfer G; Schmitt G
    Strahlentherapie; 1985 Dec; 161(12):797-800. PubMed ID: 4082216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different stopping volumes of clinical pion beams at TRIUMF on the mouse small intestine.
    Saito T; Chaplin DJ; Lam GK; Skarsgard LD
    Radiat Res; 1989 Jan; 117(1):8-20. PubMed ID: 2492379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic pion irradiation of unresectable soft tissue sarcomas.
    Greiner RH; Blattmann HJ; Thum P; Coray A; Crawford JF; Kann RH; Munkel G; Pedroni E; von Essen CF; Zimmermann A
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1077-83. PubMed ID: 2808041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4: a pilot study.
    Goodman GB; Skarsgard LD; Thompson GB; Harrison R; Lam GK; Lugate C
    Radiother Oncol; 1990 Jan; 17(1):21-8. PubMed ID: 2157239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary report on long-term results of pion therapy at Los Alamos.
    von Essen CF
    Radiat Med; 1983; 1(4):314-9. PubMed ID: 6680210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pion irradiation at Paul Scherrer Institute. Results of dynamic treatment of unresectable soft tissue sarcoma.
    Greiner R; Munkel G; Kann R; Blattmann H; Coray A; Thum P; Zimmermann A
    Strahlenther Onkol; 1990 Jan; 166(1):30-3. PubMed ID: 2300888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pion radiation therapy of non-resectable bone- and soft tissue sarcomas at the Swiss Institute for Nuclear Research].
    Thum P; Greiner R; Blattmann H; Coray A; Zimmermann A
    Schweiz Med Wochenschr; 1988 Mar; 118(10):333-40. PubMed ID: 2452478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a bolus and inhomogeneities on pion stopping distributions.
    Wright HA; Turner JE; Hamm RN
    Med Phys; 1984; 11(6):751-4. PubMed ID: 6439988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.